Inherited Cardiomyopathies and the Role of Mutations in Non-coding Regions of the Genome
Overview
Affiliations
Cardiomyopathies (CMs) are a group of cardiac pathologies caused by an intrinsic defect within the myocardium. The relative contribution of genetic mutations in the pathogenesis of certain CMs, such as hypertrophic cardiomyopathy (HCM), arrythmogenic right/left ventricular cardiomyopathy (ARVC) and left ventricular non-compacted cardiomyopathy (LVNC) has been established in comparison to dilated cardiomyopathy (DCM) and restrictive cardiomyopathy (RCM). The aim of this article is to review mutations in the non-coding parts of the genome, namely, microRNA, promoter elements, enhancer/silencer elements, 3'/5'UTRs and introns, that are involved in the pathogenesis CMs. Additionally, we will explore the role of some long non-coding RNAs in the pathogenesis of CMs.
Recent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies.
Zhao M, He X, Min X, Yang H, Wu W, Zhong J Rev Cardiovasc Med. 2025; 26(2):25132.
PMID: 40026515 PMC: 11868910. DOI: 10.31083/RCM25132.
Technologies for Targeted RNA Degradation and Induced RNA Decay.
Mikutis S, Bernardes G Chem Rev. 2024; 124(23):13301-13330.
PMID: 39499674 PMC: 11638902. DOI: 10.1021/acs.chemrev.4c00472.
Cardiomyopathy: pathogenesis and therapeutic interventions.
Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.
PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.
The role of noncoding genetic variants in cardiomyopathy.
Htet M, Lei S, Bajpayi S, Zoitou A, Chamakioti M, Tampakakis E Front Cardiovasc Med. 2023; 10:1116925.
PMID: 37283586 PMC: 10239966. DOI: 10.3389/fcvm.2023.1116925.
Role of non-coding variants in cardiovascular disease.
Heshmatzad K, Naderi N, Maleki M, Abbasi S, Ghasemi S, Ashrafi N J Cell Mol Med. 2023; 27(12):1621-1636.
PMID: 37183561 PMC: 10273088. DOI: 10.1111/jcmm.17762.